Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-08-13

FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for dicyclomine hydrochloride, resulting in updated labeling for Actavis Pharma’s product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dicyclomine hydrochloride (Dicyclomine hydrochloride)

Snippet

SUPPL AP for DICYCLOMINE HYDROCHLORIDE (DICYCLOMINE HYDROCHLORIDE)